Work

HSR25-171: Risk of Health-Related Quality of Life (HRQOL) Events in Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7315

Authors: Daniel Thomas Jones, Abbas Hussain, Hazem Aboaid, Riccesha Hattin, Savannah Schauer, Tal Schlesinger, Rory Twells, Karl Aharonian, Ryan Parto, Rodd Rahmani, Chalette Lambert-Swainston, Ramaditya Srinivasmurthy, Kyaw Zin Thein

Institutions: Touro University Nevada, University of Nevada, Las Vegas, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408958784

FWCI: 0.281

Cites:

Cited by: 1

Related to: 10